Fennec Pharmaceuticals(DE:RV41)
€9.35+-0.25 (+6.25%)
DE:RV41
Fennec Pharmaceuticals Revenue
€9.35
At close:+-0.25 (+6.25%)
Fennec Pharmaceuticals (RV41) Revenue
0 Followers
Fennec Pharmaceuticals Revenue
Fennec Pharmaceuticals had a revenue of 17.87M in the quarter ending Jun 30, 2026, with 18.31%. This bring the company's revenue in the last twelve months to 59.22M, Increased 16.12%. In the fiscal year ending Dec 31, 2025, Fennec Pharmaceuticals had annual revenue of 44.64M with -6.09% growth.
- Revenue (ttm)
- 59.22M
- Revenue Growth
- 65.92%
- P/S Ratio
- 7.49
- Revenue/Employee
- EUR 1,275,486
- Employees
- 35
- Market Cap
- EUR 334.35M
Revenue Chart
Fennec Pharmaceuticals Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 44.64M | -2.90M | -6.09% |
| Dec 31, 2024 | 47.54M | 26.29M | 123.69% |
| Dec 31, 2023 | 21.25M | 19.72M | 1284.50% |
| Dec 31, 2022 | 1.53M | 1.53M | ― |
| Dec 31, 2021 | 0.00 | -170.00K | -100.00% |
| Dec 31, 2020 | 170.00K | 170.00K | ― |
| Dec 31, 2019 | 0.00 | 0.00 | ― |
| Dec 31, 2018 | 0.00 | 0.00 | ― |
| Dec 31, 2017 | 0.00 | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.